1st Quarter - Report

INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE

Firm
Client
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. S. 1002 SAFE DOSES ACT of 2011. All provisions. Potential prescription drug track-and-trace legislation.

LobbyistCovered position, as disclosed
MARK EUGENE KINNEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1002 (112th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.